Silo Pharma (SILO) Profit After Tax (2010 - 2026)

Silo Pharma has reported Profit After Tax for 13 years, with the latest figure at -$1.6 million in Q1 2026.

• Quarterly Profit After Tax fell 59.69% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (down 4.74% YoY) and the FY2025 annual result came in at -$4.2 million, up 3.76% from the prior year.
• Profit After Tax fell to -$1.6 million in Q1 2026 per SILO's latest filing, from -$881530.0 in the prior quarter.
• Over five years, Profit After Tax peaked at -$604072.0 in Q1 2022 and troughed at -$1.7 million in Q4 2024.
• A 5-year average of -$1.1 million and a median of -$983246.0 in 2022 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2022 and 2025: Profit After Tax sank 115.4% in 2022, then soared 49.06% in 2025.
• Over 5 years, Profit After Tax stood at -$1.7 million in 2022, then jumped by 32.57% to -$1.1 million in 2023, then plunged by 54.36% to -$1.7 million in 2024, then jumped by 49.06% to -$881530.0 in 2025, then tumbled by 86.85% to -$1.6 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$1.6 million, -$881530.0, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.